Use of gaboxadol in the treatment of diabetes and related diseases

摘要

Methods and compositions for treating a metabolic disease include administering gaboxadol or a pharmaceutically acceptable salt thereof to a patient diagnosed with the metabolic disease. In examples, administering gaboxadol or a pharmaceutically acceptable salt thereof to a patient diagnosed with metabolic disease is HbA1c level, fasting plasma glucose level, 2-hour oral glucose loading test (OGTT) result level, and random plasma Effective for lowering one or more of the glucose levels. Gaboxadol or a pharmaceutically acceptable salt thereof can be administered, optionally in combination with a hypoglycemic agent.